Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 7,957-7,968 of 10,592
Drug study icon
CompletedNCT00322764

RG2417 for depression

This study is completed in the United States. It is testing RG2417 for depression.

In United States
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Repligen Corporation
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00686998

Phase IIA Study in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AstraZeneca
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06634277

Philly NavSTAR Implementation study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
Friends Research Institute, Inc.
Condition
Addiction
Drug study icon
WithdrawnNCT01905605

Phosphatidylcholine Supplementation in Infants

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 1 Week to 7 Weeks
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.